An MMP13-Selective Inhibitor Delays Primary Tumor Growth and the Onset of Tumor-Associated Osteolytic Lesions in Experimental Models of Breast Cancer

• Manisha Shah ,

  * E-mail: manisha@medstv.unimelb.edu.au

  Affiliation St. Vincent's Institute of Medical Research, St. Vincent's Hospital, Melbourne, Australia

  ⨯
• Dexing Huang,

  Affiliation St. Vincent's Institute of Medical Research, St. Vincent's Hospital, Melbourne, Australia

  ⨯
• Tony Blick,

  Affiliation St. Vincent's Institute of Medical Research, St. Vincent's Hospital, Melbourne, Australia

  ⨯
• Andrea Connor,

  Affiliations St. Vincent's Institute of Medical Research, St. Vincent's Hospital, Melbourne, Australia, University of Melbourne Department of Surgery, St. Vincent's Hospital, Melbourne, Australia

  ⨯
• Lawrence A. Reiter,

  Affiliation Pfizer Global Research and Development, Groton Laboratories, Groton, Connecticut, United States of America

  ⨯
• Joel R. Hardink,

  Affiliation Pfizer Global Research and Development, Groton Laboratories, Groton, Connecticut, United States of America

  ⨯
• Conor C. Lynch,

  Affiliation H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America

  ⨯
• Mark Waltham,

  Affiliation St. Vincent's Institute of Medical Research, St. Vincent's Hospital, Melbourne, Australia

  ⨯
• Erik W. Thompson

  Affiliations St. Vincent's Institute of Medical Research, St. Vincent's Hospital, Melbourne, Australia, University of Melbourne Department of Surgery, St. Vincent's Hospital, Melbourne, Australia

  ⨯